Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 83,431 | 85,806 | 84,688 | 83,383 | 80,137 |
| Cost of Goods | 46,923 | 52,629 | 47,865 | 50,002 | 44,885 |
| Gross Profit | 36,508 | 33,177 | 36,823 | 33,381 | 35,252 |
| Operating Expenses | 33,914 | 36,728 | 30,208 | 33,627 | 33,733 |
| Operating Income | 3,517 | -2,922 | 7,480 | -244 | 2,404 |
| Interest Expense | 175 | 35 | 76 | 43 | 22 |
| Other Income | 3,736 | 1,453 | -1,599 | 1,473 | -800 |
| Pre-tax Income | 7,078 | -1,504 | 5,805 | 1,186 | 1,582 |
| Income Tax | 2,285 | -75 | 2,280 | 431 | 598 |
| Net Income Continuous | 4,793 | -1,429 | 3,525 | 755 | 984 |
| Minority Interests | 874 | -1,237 | -424 | 1,781 | -326 |
| Net Income | $3,919 | $-192 | $3,949 | $-1,026 | $1,310 |
| EPS Basic Total Ops | 0.08 | 0.00 | 0.09 | -0.02 | 0.03 |
| EPS Basic Continuous Ops | 0.10 | -0.03 | 0.08 | 0.02 | 0.02 |
| EPS Diluted Total Ops | 0.08 | 0.00 | 0.08 | -0.03 | 0.03 |
| EPS Diluted Continuous Ops | 0.10 | -0.03 | 0.07 | 0.01 | 0.02 |
| EBITDA(a) | $9,194 | $2,144 | $12,454 | $4,562 | $6,871 |